Results 11 to 20 of about 4,128,106 (288)
The direct costs of drug-induced skin reactions [PDF]
Objective The aim of the study was an assessment of direct costs of patients hospitalised for for skin adverse drug reactions during 2002–2012 in the Department of Dermatology at the Military Institute of Medicine (Ministry of Defence) in Warsaw.
Nina Kiepurska +4 more
doaj +3 more sources
The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania [PDF]
Background The development of antimalarial drug resistance has led to increasing calls for the introduction of artemisinin-based combination therapy (ACT).
Abdulla Salim +8 more
doaj +2 more sources
Drug-cost trajectories after national volume-based procurement in Chinese public hospitals: a 31-province interrupted time-series analysis [PDF]
BackgroundChina's national volume-based procurement (NVBP) policy reduced prices for selected medicines, but national aggregate drug-cost trends are exposed to concurrent reforms and nonlinear prepolicy trajectories. We assessed public-hospital drug-cost
Jing Mao, Guangqi Liu
doaj +2 more sources
A systematic review of observational studies evaluating costs of adverse drug reactions
Francisco Batel Marques,1,2 Ana Penedones,1,2 Diogo Mendes,1,2 Carlos Alves,1,2 1CHAD – Centre for Health Technology Assessment and Drug Research, AIBILI – Association for Innovation and Biomedical Research on Light and Image, 2School of ...
Batel Marques F +3 more
doaj +1 more source
Outcome Measurements in Economic Evaluations of Drug Misuse Interventions [PDF]
This thesis critically evaluates the measurement of outcomes in economic evaluations of drug misuse interventions. Three different aspects of measuring outcomes are examined: one focusing on non-monetary outcomes at the individual patient level; one ...
Chang, Ching-Wen
core +4 more sources
Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. [PDF]
BACKGROUND: Injection site infections among injecting drug users (IDUs) have been associated with serious morbidity and health service costs in North America.
Ncube, F +14 more
core +1 more source
Tuberculosis (TB) programs depend on a continuous supply of large amounts of high-quality TB drugs. When TB programs procure TB drugs from international suppliers, such as the Global Drug Facility, they can incur import costs for international transport,
Stefan Kohler +3 more
doaj +2 more sources
This paper reports on the willingness of HIV/AIDS patients to pay for the most affordable triple therapy combination of antiretrovirals in a local setting in Cameroon.
Kenneth Ngwambokong Muko +5 more
doaj +1 more source
Objectives Value‐based pricing of oncology drugs provides a best estimate for the price of a drug, as it relates to the benefits it provides for individual patients. To date, the impact of value‐based pricing to reference cost‐effectiveness thresholds (λ)
Ambica Parmar +3 more
doaj +1 more source

